Skip to content

Dogwood Therapeutics DWTX Change in Other Assets

Change in Other Assets at other companies

Eli Lilly logo
Eli LillyLLY
$1.65B+98.4%
Pfizer logo
PfizerPFE
-$322.25M+61.9%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
-$4.13M-140%
Avanos Medical logo
Avanos MedicalAVNS
$2.4M+900%
LON
LeonaBio, Inc. Common StockLONA
$396K+212%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
-$1.43M-63.0%

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Reported directly by Dogwood Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's change in other assets?
Dogwood Therapeutics (DWTX) reported change in other assets of -$288.89K in Q1 2026.
How has Dogwood Therapeutics's change in other assets changed year-over-year?
Dogwood Therapeutics's change in other assets decreased by 302.3% year-over-year, from -$71.81K to -$288.89K.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.